Change search criteria ↓

Search results

42 projects found matching your search criteria:

  1. 1. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Principal investigator: dr Ewa Monika Szymańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 8, Panel: NZ7

  2. 2. Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disord…

    Principal investigator: Michał Kamiński

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  3. 3. Cellulose-pectin hydrogels cross-linked with divalent metal ions for immobilization of antagonistic microorganisms

    Principal investigator: dr hab. Justyna Cybulska

    Instytut Agrofizyki im. Bohdana Dobrzańskiego PAN

    Call: OPUS 19, Panel: NZ9

  4. 4. The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its…

    Principal investigator: dr hab. Paweł Maga

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 17, Panel: NZ5

  5. 5. New vanilloid type 1 receptor (TRPV1) antagonists in the search for substances with wide-spectrum of anticonvulsant and …

    Principal investigator: dr hab. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  6. 6. Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - gliobl…

    Principal investigator: prof. Aleksandra Misicka-Kęsik

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 13, Panel: NZ7

  7. 7. Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

    Principal investigator: dr Łukasz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA 11, Panel: NZ7

  8. 8. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese…

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

    Call: OPUS 9, Panel: ST5

  9. 9. Clinical efficacy of pharmacotherapy with antihistaminics and leukotriene antagonists and the therapy impact on cyclooxy…

    Principal investigator: Paulina Maria Korczyńska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 1, Panel: NZ5

  10. 10. Quantitative assessment of vascular endothelial growth factor (VEGF) in serum, follicular fluid (FF) and VEGF mRNA in gr…

    Principal investigator: prof. Artur Jacek Jakimiuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 1, Panel: NZ5

  11. 11. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  12. 12. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Principal investigator: Magdalena Maria Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 20, Panel: ST4

  13. 13. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan…

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

    Call: OPUS 19, Panel: NZ7

  14. 14. Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1…

    Principal investigator: Aneta Sylwia Nieznańska

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  15. 15. Prognostic value of platelet-derived microRNAs in patients with acute coronary syndrome treated with novel P2Y12 recepto…

    Principal investigator: dr hab. Aleksandra Gąsecka-van der Pol

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

    Call: PRELUDIUM 16, Panel: NZ7

  16. 16. Development of macrocyclic peptide antagonists of the PD-1/PD-L1 pathway. Charcterization of simultaneous administration…

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA 14, Panel: NZ7

  17. 17. Non-vitamin K antagonist oral anticoagulants (NOACs) as modulators of valvular calcification and inflammation in aortic …

    Principal investigator: dr hab. Joanna Natorska

    Krakowski Szpital Specjalistyczny im. Jana Pawła II

    Call: OPUS 15, Panel: NZ5

  18. 18. Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen…

    Principal investigator: prof. Grażyna Chłoń-Rzepa

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 15, Panel: NZ7

  19. 19. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc…

    Principal investigator: Michał Karol Załuski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 12, Panel: NZ7

  20. 20. Non-quinazoline antagonists of apha1 and 5-HT2A receptors with pleiotropic effects as a new perspective for hypertension…

    Principal investigator: dr Monika Kubacka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 8, Panel: NZ7

  21. 21. Design and synthesis of phosphoroorganic antagonists of BIR domain of apoptosis inhibitor proteins (IAP)

    Principal investigator: dr Agnieszka Łupicka-Słowik

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 7, Panel: ST5

  22. 22. Influence of antagonists (scopolamine and 3-quinuclidinyl benzilate) and agosists (carbachol) of muscarinic cholinergic …

    Principal investigator: Szymon Piotr Chowański

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: PRELUDIUM 5, Panel: NZ9

  23. 23. Structure-activity relationship of bifunctional peptides, agonists of opioid receptors and antagonists of neurokinin rec…

    Principal investigator: Jolanta Dyniewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 2, Panel: ST5

  24. 24. Analysis of the anti-nociceptive and anti-inflammatory action of histamine H4 receptor antagonist in inflammatory nocice…

    Principal investigator: Przemysław Rzodkiewicz

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

    Call: PRELUDIUM 2, Panel: NZ4

  25. 25. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig…

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 1, Panel: NZ2

  26. 26. Synthesis and marking the activity of new potential antagonists of receptors for excitatory amino acids which have the s…

    Principal investigator: prof. Aleksander Paweł Mazurek

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  27. 27. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: OPUS 23, Panel: NZ7

  28. 28. Narcissism in the World of Politics: Investigation into the role of four narcissistic facets in predicting pro- versus a…

    Principal investigator: dr hab. Marta Marchlewska

    Instytut Psychologii PAN

    Call: SONATA BIS 13, Panel: HS6

  29. 29. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  30. 30. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 20, Panel: NZ2

  31. 31. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur…

    Principal investigator: Marcin Józef Drop

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 17, Panel: NZ7

  32. 32. Application of machine learning based artificial intelligence to search for substances that modulate the activity of ROR…

    Principal investigator: dr hab. Marcin Marek Ratajewski

    Instytut Biologii Medycznej PAN

    Call: OPUS 17, Panel: NZ7

  33. 33. Environmental quality and intensity of sexual conflict

    Principal investigator: Aleksandra Łukasiewicz

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: PRELUDIUM 12, Panel: NZ8

  34. 34. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 12, Panel: NZ7

  35. 35. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param…

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ7

  36. 36. Estrogen receptor GPER as a modulator of inflammatory and functional gastrointestinal diseases and colorectal cancer

    Principal investigator: Damian Jacenik

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 9, Panel: NZ5

  37. 37. Factors involved in antibacterial activity of Pseudomonas sp. P482 strain against plant pathogenic bacteria from Dicekya…

    Principal investigator: dr hab. Sylwia Justyna Jafra

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: OPUS 4, Panel: NZ9

  38. 38. LCAP biomimetics - alicyclic amine derivatives as a new class of monoaminergic receptor ligands

    Principal investigator: dr hab. Paweł Maria Zajdel

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 3, Panel: NZ7

  39. 39. Brain regions that mediate antipsychotic-induced changes in oscillatory activity recorded in the nucleus accumbens

    Principal investigator: dr Mark Jeremy Hunt

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 2, Panel: NZ4

  40. 40. Opioid receptors in the basal ganglia of the brain as targets for alcohol abuse therapy.

    Principal investigator: dr Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

    Call: OPUS 2, Panel: NZ4

  41. 41. Histamine H3/H4 receptors as the attractive target for the search of biologically active substances

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: MAESTRO 1, Panel: NZ4

  42. 42. Characteristics and significance of hydrolases from Stenotrophomonas maltophilia and their participation in biological c…

    Principal investigator: dr Urszula Marzena Jankiewicz

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Rolnictwa i Biologii

    Call: OPUS 1, Panel: NZ9

Graphic design and implementation: Jakub Piotrowski